Eli Lilly & Company (NYSE:LLY) is one of the 10 Best Non-Tech Stocks to Buy According to Reddit, supported by hedge fund interest.
Eli Lilly & Company (NYSE:LLY) gained attention on September 29 when Guggenheim reaffirmed its Buy rating with a price target of $875.
The analyst noted that there was strong demand for tirzepatide in the treatment of diabetes and obesity and that the impending launch of orforglipron will support global growth. The investment firm highlighted Eli Lilly & Company (NYSE:LLY)’s impressive financials, highlighting operational efficiency with a gross profit margin of 82.64%, alongside a revenue increase of 36.83% over the previous year.
Furthermore, the U.S. Food and Drug Administration authorized Guardant Health’s Guardant360 CDx as a companion diagnostic for Eli Lilly & Company (NYSE:LLY)’s breast cancer medication Inluriyo (imlunestrant) that same day, making it possible to identify patients with advanced breast cancer who have an ESR1 mutation.
Moreover, Eli Lilly & Company (NYSE:LLY)’s progress in the metabolic and oncology industries is highlighted by this simultaneous boost from analyst confidence as well as regulatory approval, which solidifies the company’s position as a leading pharmaceutical company worldwide.
Leading pharmaceutical company Eli Lilly & Company (NYSE:LLY) creates, produces, and markets cutting-edge medications in a variety of therapeutic areas. It is one of the Best Non-Tech Stocks.
While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 11 Best Gold Royalty and Small-Cap Gold Stocks to Invest in Now and 11 Best Coal Stocks to Buy According to Hedge Funds.
Disclosure: None.